Sin-Hang FUNG

Ms. Sin-Hang FUNG


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PLPaul Lee
Paul Lee
RYRita Lok Hay Yim
Rita Lok Hay Yim
SFSin-Hang FUNG
Sin-Hang FUNG
KMKai Kei Miu
Kai Kei Miu
CWCindy WANG
Cindy WANG
HGHarinder Gill
Harinder Gill
Myelodysplastic syndrome (MDS) is a clonal myeloid neoplasm characterized by ineffective hematopoiesis, cytopenia, dysplasia, and clonal instability, leading to leukemic transformation. Hypomethylating agents are the mainstay of treatment in higher-risk MDS. However, treatment resistance and disease transformation into acute myeloid leukemia (AML) is observed in the majority of patients and is indicative of a dismal outcome. The residual cell clones resistant to therapy or cell clones acquiring new genetic aberrations are two of the key events responsible for drug resistance. Bulk tumor sequencing often fails to detect these rare subclones that confer resistance to therapy. In this study, we employed a single-cell DNA (sc-DNA) sequencing approach to study the clonal heterogeneity and clonal evolution in two MDS patients refractory to HMA. In both patients, different single nucleotide variations (SNVs) or insertions and deletions (INDELs) were detected with bulk tumor sequencing. Rare cell clones with mutations that are undetectable by bulk tumor sequencing were detected by sc-DNA sequencing. In addition to SNVs and short INDELs, this study also revealed the presence of a clonal copy number loss of DNMT3A, TET2, and GATA2 as standalone events or in association with the small SNVs or INDELs detected during HMA resistance and disease progression.

Verified
Journal Article
Open access
PDF file
PLPaul Lee
Paul Lee
RYRita Lok Hay Yim
Rita Lok Hay Yim
KMKai Kei Miu
Kai Kei Miu
SFSin-Hang FUNG
Sin-Hang FUNG
JLJinyue Liao
Jinyue Liao
HGHarinder Gill
Harinder Gill
In myelodysplastic syndrome (MDS), resistance to hypomethylating agents (HMA) portends a poor prognosis, underscoring the importance of understanding the molecular mechanisms leading to HMA-resistance. In this study, P39 and Kasumi-1 cells and their azacitidine-resistant and decitabine-resistant sublines were evaluated comparatively with transcriptomic and methylomic analyses. Expression profiling and genome-wide methylation microarray showed downregulation of PTEN associated with DNA hypermethylation in P39 cell lines resistant to azacitidine and decitabine. This pattern of PTEN dysregulation was also confirmed in a cohort of patients failing treatment with HMA. DNA hypomethylation of MDM2 was detected with downregulation of MDM2 in HMA resistant cell lines. Long-read sequencing revealed significant RNA hypomethylation of MDM2 resulting in alternative splicing and production of a truncated MDM2 transcript in azacitidine-resistant P39 cells. The expression of this MDM2 truncated transcript was also significantly increased in HMA-resistant patients compared with HMA-responsive patients. In conclusion, epigenetic and epi-transcriptomic dysregulation of PTEN and MDM2 were associated with resistance to hypomethylating agents.

13 August 2026 in Genome Biology
Verified
Journal Article
Open access
PDF file
SFSin-Hang FUNG
Sin-Hang FUNG
ZZZhenghao Zhang
Zhenghao Zhang
RWRan Wang
Ran Wang
CMChen Miao
Chen Miao
BWBrian Shing-Hei Wong
Brian Shing-Hei Wong
QCQin Cao
Qin Cao
Large language models can learn new tasks through in-context learning (ICL), yet this ability remains underexplored for biological sequence classification. We evaluate ICL across 20 large language models on three antibody tasks: species-origin, antibody specificity, and isotype class classification. Few-shot prompting improves over zero-shot performance, but matching the performance of protein language model classifiers requires sequence-similar demonstrations. Building on this observation, we introduce a sequence similarity-based strategy for ICL in antibody sequence classification, Sim-ICL. Using 32-shot prompting, Sim-ICL achieves competitive performance on two of three tasks. Its simplicity makes few-shot ICL promising for antibody characterization, especially for researchers with limited coding expertise.